Skip to content

Study on TCM Treatment of Idiopathic Pulmonary Fibrosis

Study on TCM Treatment of Idiopathic Pulmonary Fibrosis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17013532
Enrollment
Unknown
Registered
2017-11-24
Start date
2016-10-10
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

trial group:Chinese medicine granules
Control group:Chinese placebo

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with IPF stable patient diagnosis; 2. Aged 40 to 80 years old; 3. In accordance with the diagnostic criteria of TCM; 4. Not been included in other drug trials within one month; 5. Sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. In acute exacerbation of IPF patients; 2. Pregnant or lactating women and recent pregnancy plan patients; 3. With conscious disturbance, dementia or psychotic disorders; 4. Severe cardiac insufficiency, liver and kidney disease (ALT, AST, BUN, Cr higher than normal on-line were 1 times), neurological diseases, cancer patients; 5. Known to be allergic to therapeutic drugs.

Design outcomes

Primary

MeasureTime frame
lung function;acute exacerbation of hospitalization of IPF;

Secondary

MeasureTime frame
clinical symptoms;dyspnea score;quality of life;walk test of 6min;

Countries

China

Contacts

Public ContactXue-qing Yu

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

yxqshi@163.com+86 13525518843

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026